Literature DB >> 18751470

Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.

Sirilak Disatian1, E J Ehrhart, Sarah Zimmerman, E Christopher Orton.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Myxomatous mitral valve disease is a common naturally occurring heart disease of dogs that is pathologically similar to myxomatous mitral valve disease in humans. It was hypothesized that interstitial cell phenotype transformation recently described in human myxomatous valves might also occur in dogs with myxomatous mitral valves, and correlate with disease severity.
METHODS: Normal and early-, intermediate- and late-stage myxomatous canine mitral valves were examined histologically and immunohistochemically for cytoskeletal (vimentin, desmin, smooth muscle alpha-actin, smooth muscle myosin, and non-muscle myosin), collagenolytic (MMP-1, MMP-13), cell surface (CD-31, CD-45, CD-68) and proliferation (Ki-67) proteins.
RESULTS: Normal canine mitral valve interstitial cells were positive for vimentin, but negative for alpha-actin, desmin and non-muscle myosin (i.e., fibroblast phenotype). Interstitial cells from myxomatous valves showed progressive positive staining for alpha-actin and desmin, but were negative for smooth muscle myosin (i.e., myofibroblast phenotype). Positive-staining cells first appeared as cellular clusters in the subendocardial region of the lamina atrialis and extended into deeper layers with increasing severity. Interstitial cells from myxomatous valves showed positive staining for non-muscle myosin (i.e., activated mesenchymal cell phenotype). Positive-staining cells increased with disease severity and were dispersed throughout the valve layers. The expression of MMP-1 and MMP-13 increased in myxomatous mitral valves and correlated with disease severity. Interstitial cellularity increased dramatically in degenerative mitral valves, though Ki-67 staining was only mildly increased.
CONCLUSION: Two patterns of interstitial cell phenotype transformation were identified in dogs with myxomatous mitral valve disease, and both correlated with disease severity. Myofibroblast transformation characterized by positive staining for alpha-actin and desmin occurred in cellular clusters primarily in the lamina atrialis. Mesenchymal cell activation characterized by positive staining to non-muscle myosin occurred throughout the valve. The dog may be a natural model for studying the cell biology of progressive myxomatous valve disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751470

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  16 in total

Review 1.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

Review 2.  The mechanobiology of mitral valve function, degeneration, and repair.

Authors:  Jennifer M Richards; Emily J Farrar; Bruce G Kornreich; N Sydney Moїse; Jonathan T Butcher
Journal:  J Vet Cardiol       Date:  2012-02-25       Impact factor: 1.701

3.  Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture.

Authors:  Andrew S Waxman; Bruce G Kornreich; Russell A Gould; N Sydney Moïse; Jonathan T Butcher
Journal:  J Vet Cardiol       Date:  2012-03-03       Impact factor: 1.701

Review 4.  Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis.

Authors:  Francesca N Delling; Ramachandran S Vasan
Journal:  Circulation       Date:  2014-05-27       Impact factor: 29.690

5.  Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.

Authors:  Jeanne M Connolly; Marina A Bakay; James T Fulmer; Robert C Gorman; Joseph H Gorman; Mark A Oyama; Robert J Levy
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

6.  Matrix metalloproteinases and their inhibitors in canine mammary tumors.

Authors:  Luca Aresu; Mery Giantin; Emanuela Morello; Marta Vascellari; Massimo Castagnaro; Rosa Lopparelli; Vanessa Zancanella; Anna Granato; Spiridione Garbisa; Arianna Aricò; Alice Bradaschia; Franco Mutinelli; Mauro Dacasto
Journal:  BMC Vet Res       Date:  2011-07-04       Impact factor: 2.741

7.  The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure.

Authors:  Magdalena Hulanicka; Magdalena Garncarz; Marta Parzeniecka-Jaworska; Michał Jank
Journal:  BMC Genomics       Date:  2014-06-21       Impact factor: 3.969

8.  Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.

Authors:  S E Cremer; G E Singletary; L H Olsen; K Wallace; J Häggström; I Ljungvall; K Höglund; C A Reynolds; N Pizzinat; M A Oyama
Journal:  J Vet Intern Med       Date:  2014-08-21       Impact factor: 3.333

9.  Dynamic Heterogeneity of the Heart Valve Interstitial Cell Population in Mitral Valve Health and Disease.

Authors:  Tori E Horne; Matthew VandeKopple; Kimberly Sauls; Sara N Koenig; Lindsey J Anstine; Vidu Garg; Russell A Norris; Joy Lincoln
Journal:  J Cardiovasc Dev Dis       Date:  2015-08-17

Review 10.  Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human.

Authors:  Greg R Markby; Kim M Summers; Vicky E MacRae; Brendan M Corcoran
Journal:  Vet Sci       Date:  2017-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.